Worldwide Clinical Trials: A Partnership You Can Trust in Your Pulmonary Hypertension Study
Pulmonary hypertension (PH) is high blood pressure that affects the arteries in the lungs and the right side of the heart. Researchers believe that the incidence of PH-related death may in fact be higher than statistics indicate, due to its link to other system failures, such as heart attack. Research has led to improvement in patient outcomes, and the identification of various subgroups of the disease necessitates greater nuance in diagnosis and classification.
For a translational research study that combines scientific experience with clinical expertise, rely on Worldwide Clinical Trials. Found by physicians in the 1970s, Worldwide has been instrumental in groundbreaking research and the release of lifesaving drugs across a number of therapeutic areas. The key to our continued award-winning success is that we not only recognize the importance of developing new therapies but also of justifying the research and approval of more refined agents where serviceable therapeutic solutions already exist. Our relationships with key professionals in respiratory medicine and with regulatory authorities keep us abreast of any developments that have implications for the course of your project, and our accessibility for our sponsor clients ensures a transparent and successful partnership.